
Metastatic Breast Cancer 2025 UPDATE
Two Onc Docs
00:00
Key Takeaways: Treatment Algorithms and Practical Reminders
Hosts summarize main points: endocrine+CDK4/6 for ER/PR, THP/DHP for HER2, chemo±pembrolizumab for TNBC, PARP for BRCA, and T-DXd for HER2-low.
Play episode from 10:48
Transcript


